Research Paper Volume 15, Issue 14 pp 6757—6773
PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia
Figure 2. Survival analysis of AML patients with high expression versus low expression in the PARP10 group. (A) Overall survival difference of AML patients with high PARP10 expression versus low PARP10 expression. (B) Event-free survival difference of AML patients with high PARP10 expression versus low PARP10 expression. Log-rank test was used to generate the survival curves and analyze the survival difference between the high- and low-expression groups.